© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
EBPG guideline on haemodynamic instability
1Department of Internal Medicine, division of Nephrology, University Hospital Maastricht, The Netherlands, 2Department of Medicine; division of Nephrology, Ege University Medical Faculty, Izmir, Turkey, 3Nephrology Unit, SM Annunziata Hospital, Florence, Italy, 4Nephrology, Dialysis and Intensive Care Unit, Lapeyronie University Hospital, Montpellier, France, 5Department of Diagnostic and Interventional Radiology, Helios Klinikum Wuppertal, University Hospital Witten/Herdecke, Germany, 6Département de Néphrologie JE 2411-Dénutrition des Maladies Chroniques, Hôpital E Herriot, France, 7Medical Faculty University of Cologne, Medicine Clinic I, Hospital Merheim, Germany (retired), 8Nephrology Department, Reina Sofia University Hospital, Cordoba, Spain, 9Division of Nephrology and Dialysis, Bolognini Hospital, Seriate, Italy, 10Department of Renal Medicine, St. James's University Hospital, Leeds, UK, 11Department of Surgery, University Hospital Maastricht, The Netherlands, 12Department of Nephrology, Nutrition and Dietetics, Guy's and St Thomas NHS Foundation Trust, London, UK (retired), 13Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany, 14Department of Nephrology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands, and 15Nephrology Section, Department of Internal Medicine, University Hospital, Ghent, Belgium
Correspondence and offprint requests to: Jeroen P. Kooman, MD, PhD, Department of Internal Medicine, Division of Nephrology, University Hospital Maastricht, PO Box 5800 6202 AZ Maastricht, The Netherlands. Email: jkoo@sint.azm.nl
Outline
Introduction
Definition of intra-dialytic hypotension (IDH)
Incidence of IDH
Relation between IDH and outcome
Patients at risk for IDH
Pathophysiology of IDH
Prevention of IDH
1. Evaluation of the patient
1.1 Assessment of dry weight
1.2 Measurement of blood pressure and heart rate during dialysis
1.3 Cardiac evaluation
2. Lifestyle interventions
2.1 Sodium restriction
2.2 Food and caffeine intake during dialysis
3. Factors relation to the dialysis treatment
3.1 Manipulation of ultrafiltration
3.1.1 Ultrafiltration profiling
3.1.2 Blood volume controlled ultrafiltration
3.2 Dialysate composition
3.2.1 High sodium dialysis and sodium profiling
3.2.2 Dialysate buffer
3.2.3 Dialysate calcium
3.2.4 Other components of dialysate
3.3 Dialysis membranes/contamination of dialysate
3.4 Dialysate temperature
3.5 Convective techniques and isolated ultrafiltration
3.5.1 Convective techniques
3.5.2 Isolated ultrafiltration
3.6 Dialysis duration and frequency
3.7 Switch to peritoneal dialysis
4. Antihypertensive drugs and preventive medication
4.1 Antihypertensive drugs
4.2 Preventive vasoactive agents
4.3 Carnitine
5. Stratified approach to prevent IDH
6. Treatment of IDH
6.1 Trendelenburg position
6.2 Stopping ultrafiltration
6.3 Infusion fluids
6.4 Protocol
Keywords: dialysis; guideline; haemodynamic; hypotension; instability
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
Definition of intra-dialytic hypotension
In the literature, the definition of intra-dialytic hypotension (IDH) is not standardized and differs between various studies. Most definitions however, take into account either a relative or an absolute decline in blood pressure (BP) as well as the presence of specific symptoms. Although no evidence based recommendation regarding the definition of IDH can be given, the EBPG working group stresses that both a reduction in BP, as well as clinical symptoms with need for nursing intervention should be present in order to accept the presence of IDH. Moreover, the definition of IDH should ideally be equal in the literature and different treatment guidelines. Conforming to the K/DOQI guidelines, a proposed definition is a decrease in systolic BP
20 mmHg or a decrease in mean arterial pressure (MAP) by 10 mmHg associated with clinical events and need for nursing interventions.
Incidence of IDH
In reviews, a 20% incidence of intra-dialytic hypotension is widely cited
| References |
|---|
Relation between IDH and outcome
| References |
|---|
Patients at risk for IDH
| References |
|---|
Pathophysiology of IDH
| References |
|---|
| Prevention of IDH |
|---|
1. Evaluation of the patient
Rationale
Recommendations for research
| References |
|---|
Rationale
Recommendations for research
| References |
|---|
Rationale
Recommendation for research
| References |
|---|
| 2. Lifestyle interventions |
|---|
Rationale
Recommendations for research
| References |
|---|
Rationale
Recommendations for research
| References |
|---|
| 3. Factors related to the dialysis treatment |
|---|
3.1 Optimizing ultrafiltration: ultrafiltration profiling and blood volume controlled ultrafiltration
Rationale
Recommendations for research
| References |
|---|
Rationale
Recommendation for research
| References |
|---|
| 3.2 Dialysate composition |
|---|
3.2.1 Dialysate sodium
Rationale
Recommendation for research
| References |
|---|
| 3.2.2 Dialysate buffer |
|---|
Rationale
Recommendations for research
| References |
|---|
| 3.2.3 Dialysate calcium |
|---|
Rationale
Recommendations for research
| References |
|---|
| 3.2.4 Other dialysate components |
|---|
Rationale
Recommendations for research
| References |
|---|
| 3.3 Dialysis membranes and contamination of dialysate |
|---|
Rationale
Recommendations for research
| References |
|---|
| 3.4 Dialysate and body temperature |
|---|
Rationale
Recommendations for research
| References |
|---|
| 3.5 Convective techniques and isolated ultrafiltration |
|---|
Rationale
Recommendation for research
| References |
|---|
Rationale
Recommendation for research
| References |
|---|
| 3.6 Dialysis duration and frequency |
|---|
Rationale
Recommendation for research
| References |
|---|
| 3.7 Switch to peritoneal dialysis |
|---|
Rationale
Recommendations for research
| 4. Avoidance of antihypertensive drugs and prescription of vasoactive medication before dialysis |
|---|
Rationale
Recommendation for research
| References |
|---|
Rationale
Recommendations for research
| References |
|---|
Recommendations of research
| References |
|---|
| 5. Stratified approach to prevent IDH |
|---|
First-line approach
Second-line approach
Third-line approach (only if other treatment options have failed)
| 6. Treatment of IDH |
|---|
6.1 Trendelenburg position
Rationale
Recommendation for research
6.2 Stopping ultrafiltration
Rationale
Recommendation for research
6.3 Infusion fluids
Rationale
Summary of evidence
Recommendation for research
6.4 Protocol-based treatment
Rationale
Recommendation for research
| Reference |
|---|
This article has been cited by other articles:
![]() |
P. Machek, T. Jirka, U. Moissl, P. Chamney, and P. Wabel Guided optimization of fluid status in haemodialysis patients Nephrol. Dial. Transplant., September 30, 2009; (2009) gfp487v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ponce, P. Taborsky, and J. Vlasak Assessment and Reduction of fluid overload using a body composition monitor NDT Plus, June 3, 2009; (2009) sfp063v1. [Full Text] [PDF] |
||||
![]() |
R. Vanholder, D. Abramowicz, J. B. Cannata-Andia, V. Cocchi, P. Cochat, A. Covic, K.-U. Eckardt, D. Fouque, O. Heimburger, S. Jenkins, et al. The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP) NDT Plus, June 1, 2009; 2(3): 213 - 221. [Full Text] [PDF] |
||||
![]() |
F. M. van der Sande, G. Wystrychowski, J. P. Kooman, L. Rosales, J. Raimann, P. Kotanko, M. Carter, C. T. Chan, K. M.L. Leunissen, and N. W. Levin Control of Core Temperature and Blood Pressure Stability during Hemodialysis Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zoccali, D. Abramowicz, J. B Cannata-Andia, P. Cochat, A. Covic, K.-U. Eckardt, D. Fouque, O. Heimburger, A. McLeod, E. Lindley, et al. European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP) Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2162 - 2166. [Full Text] [PDF] |
||||


